3F16
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-N-(3-hydroxy-1-nitroso-1-oxopropan-2-yl)-4-methoxybenzenesulfonamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID29 |
Synchrotron site | ESRF |
Beamline | ID29 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2004-09-30 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.91677 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 51.882, 60.366, 53.953 |
Unit cell angles | 90.00, 114.37, 90.00 |
Refinement procedure
Resolution | 37.220 - 1.160 |
R-factor | 0.16301 |
Rwork | 0.161 |
R-free | 0.18172 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.006 |
RMSD bond angle | 1.127 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | MOLREP |
Refinement software | REFMAC (5.2.0005) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 1.220 |
High resolution limit [Å] | 1.160 | 1.160 |
Number of reflections | 50127 | |
<I/σ(I)> | 17 | 13 |
Completeness [%] | 96.5 | 81.8 |
Redundancy | 3.6 | 2.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 293 | 0.1M TRIS, 30% PEG 6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K |